⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 46 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 46 minutes ago
🛡️ EUSW
🇬🇧
💊 Medicine AT August 17, 2026

Montelukast Sandoz 4 mg - Kautabletten 4 mg (Kautablette)

📷 EU Safety Watch placeholder
Montelukast Sandoz 4 mg - Kautabletten 4 mg (Kautablette)
📷 EU Safety Watch placeholder
Montelukast Sandoz 4 mg chewable tablets are unavailable due to manufacturing capacity issues.
⚠️
Shortage ongoing
MONTELUKAST NATRIUM is currently in short supply in AT.
📈 Timeline
25 days active so far
August 18, 2026 September 11, 2026

What is this? This is a chewable tablet with montelukast sodium. It helps with breathing problems like asthma.

What's happening? The medicine is hard to find right now. The company cannot make enough of it.

Does this affect me? If you take this medicine, you may not be able to get it easily.

What should I do? Ask your pharmacist or doctor for help. They can suggest another option.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

ATC: R03DC03 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-08-17]

First published
August 17, 2026
Last refreshed by us
18 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Montelukast Sandoz 4 mg - Kautabletten 4 mg (Kautablette). Montelukast Sandoz 4 mg chewable tablets are unavailable due to manufacturing capacity issues.
When was this alert issued?
This alert was issued on August 17, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.